Concepedia

Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide

Yasunori Suematsu, Emi Kawachi, Yoshiaki Idemoto, Yoshino Matsuo, Takashi Kuwano, Ken Kitajima, Satoshi Imaizumi, Akira Kawamura, Keijiro Saku, Yoshinari Uehara,

International Journal of Cardiology · 2019 · 20 citations · 21 references

DOI

Concepts

References

21

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text

, , +17

Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

Steven E. Nissen, Taro Tsunoda, E. Murat Tuzcu et al. · JAMA · 2003 · 1.7K citations · Full text

, , +14

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

Anand Rohatgi, Amit Khera, Jarett D. Berry et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text

, , +16

Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol

Mohamad Navab, G.M. Anantharamaiah, Susan Hama et al. · Circulation · 2002 · 400 citations

, , +17

The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

Margarita de la Llera-Moya, Denise Drazul‐Schrader, Bela F. Asztalos et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 386 citations · Full text

, , +8